Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-27 2:17 pm Sale | 2026-03-13 | 13G | VOYAGER THERAPEUTICS INC VYGR | VANGUARD GROUP INC | 0 0.000% | -2,529,668 (Position Closed) | Filing History |
| 2026-02-18 11:15 am Sale | 2025-12-31 | 13G | VOYAGER THERAPEUTICS INC VYGR | ARMISTICE CAPITAL LLC | 4,000,000 7.190% | -200,000 (-4.76%) | Filing History |
| 2026-02-17 6:21 pm Sale | 2025-12-31 | 13G | VOYAGER THERAPEUTICS INC VYGR | EcoR1 Capital LLC | 4,002,847 6.800% | -789 (-0.02%) | Filing History |
| 2026-01-26 4:05 pm Purchase | 2026-01-16 | 13G | VOYAGER THERAPEUTICS INC VYGR | Integrated Core Strategies (US) LLC | 3,407,969 6.100% | 3,407,969 (New Position) | Filing History |
| 2025-11-14 6:30 pm Sale | 2025-09-30 | 13G | VOYAGER THERAPEUTICS INC VYGR | ARMISTICE CAPITAL LLC | 4,200,000 7.570% | -600,000 (-12.50%) | Filing History |
| 2025-11-14 3:47 pm Sale | 2025-09-30 | 13G | VOYAGER THERAPEUTICS INC VYGR | EcoR1 Capital LLC | 4,003,636 6.800% | -1,614,083 (-28.73%) | Filing History |
| 2025-08-14 9:40 pm Sale | 2025-06-30 | 13G | SCILEX HLDG CO COM SCLX | ARMISTICE CAPITAL LLC | 4,800,000 8.650% | -636,000 (-11.70%) | Filing History |
| 2025-05-15 3:22 pm Purchase | 2025-03-31 | 13G | VOYAGER THERAPEUTICS INC VYGR | ARMISTICE CAPITAL LLC | 5,436,000 9.850% | 40,000 (+0.74%) | Filing History |
| 2025-04-24 09:12 am Sale | 2025-03-31 | 13G | VOYAGER THERAPEUTICS INC VYGR | BlackRock Inc. BLK | 3,525,532 6.400% | -1,934,409 (-35.43%) | Filing History |
| 2025-02-14 5:24 pm Purchase | 2024-12-31 | 13G | VOYAGER THERAPEUTICS INC VYGR | ARMISTICE CAPITAL LLC | 5,396,000 9.880% | 196,000 (+3.77%) | Filing History |
| 2024-11-14 6:13 pm Purchase | 2024-09-30 | 13G | VOYAGER THERAPEUTICS INC VYGR | EcoR1 Capital LLC | 5,617,719 9.990% | 1,766,212 (+45.86%) | Filing History |
| 2024-11-14 5:12 pm Purchase | 2024-09-30 | 13G | VOYAGER THERAPEUTICS INC VYGR | ARMISTICE CAPITAL LLC | 5,200,000 9.540% | 964,000 (+22.76%) | Filing History |
| 2024-08-07 4:10 pm Purchase | 2024-07-31 | 13G | VOYAGER THERAPEUTICS INC VYGR | BlackRock Inc. BLK | 5,459,941 10.000% | 2,827,262 (+107.39%) | Filing History |
| 2024-02-14 4:19 pm Sale | 2023-12-31 | 13G | VOYAGER THERAPEUTICS INC VYGR | Third Rock Ventures III L.P. | 186,423 0.400% | -5,279,211 (-96.59%) | Filing History |
| 2024-02-14 2:35 pm Purchase | 2023-12-31 | 13G | VOYAGER THERAPEUTICS INC VYGR | ARMISTICE CAPITAL LLC | 4,236,000 9.630% | 840,000 (+24.73%) | Filing History |
| 2024-02-13 5:17 pm Purchase | 2023-12-29 | 13G | VOYAGER THERAPEUTICS INC VYGR | VANGUARD GROUP INC | 2,529,668 5.750% | 574,496 (+29.38%) | Filing History |
| 2024-01-29 5:25 pm Purchase | 2023-12-31 | 13G | VOYAGER THERAPEUTICS INC VYGR | BlackRock Inc. BLK | 2,632,679 6.000% | 1,690,013 (+179.28%) | Filing History |
| 2023-02-24 06:15 am Purchase | 2023-02-23 | 13D | VOYAGER THERAPEUTICS INC VYGR | NEUROCRINE BIOSCIENCES INC NBIX | 8,575,316 19.900% | 4,395,588 (+105.16%) | Filing History |
| 2023-02-14 4:02 pm Sale | 2022-12-31 | 13G | VOYAGER THERAPEUTICS INC VYGR | Third Rock Ventures III L.P. | 5,465,634 14.200% | -3,953,663 (-41.97%) | Filing History |
| 2023-02-14 1:44 pm Purchase | 2022-12-31 | 13G | VOYAGER THERAPEUTICS INC VYGR | ARMISTICE CAPITAL LLC | 3,396,000 8.800% | 3,396,000 (New Position) | Filing History |